AU2001240653A1 - Novel galenical form for oral administration with prolonged release of molsidomine - Google Patents
Novel galenical form for oral administration with prolonged release of molsidomineInfo
- Publication number
- AU2001240653A1 AU2001240653A1 AU2001240653A AU2001240653A AU2001240653A1 AU 2001240653 A1 AU2001240653 A1 AU 2001240653A1 AU 2001240653 A AU2001240653 A AU 2001240653A AU 2001240653 A AU2001240653 A AU 2001240653A AU 2001240653 A1 AU2001240653 A1 AU 2001240653A1
- Authority
- AU
- Australia
- Prior art keywords
- molsidomine
- oral administration
- prolonged release
- galenical form
- novel galenical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XLFWDASMENKTKL-UHFFFAOYSA-N Molsidomine Chemical compound O1C(N=C([O-])OCC)=C[N+](N2CCOCC2)=N1 XLFWDASMENKTKL-UHFFFAOYSA-N 0.000 title 1
- 229960004027 Molsidomine Drugs 0.000 title 1
- 230000002035 prolonged Effects 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR00/02307 | 2000-02-24 | ||
| FR0002307A FR2805462B1 (en) | 2000-02-24 | 2000-02-24 | NEW ORAL GALENIC FORM WITH EXTENDED RELEASE OF MOLSIDOMINE |
| PCT/EP2001/002055 WO2001062256A1 (en) | 2000-02-24 | 2001-02-22 | Novel galenical form for oral administration with prolonged release of molsidomine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2001240653A1 true AU2001240653A1 (en) | 2001-11-15 |
| AU2001240653B2 AU2001240653B2 (en) | 2005-05-26 |
| AU2001240653B9 AU2001240653B9 (en) | 2005-10-27 |
Family
ID=8847342
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001240653A Expired AU2001240653B9 (en) | 2000-02-24 | 2001-02-22 | Novel galenical form for oral administration with prolonged release of molsidomine |
| AU4065301A Pending AU4065301A (en) | 2000-02-24 | 2001-02-22 | Novel galenical form for oral administration with prolonged release of molsidomine |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU4065301A Pending AU4065301A (en) | 2000-02-24 | 2001-02-22 | Novel galenical form for oral administration with prolonged release of molsidomine |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US7767227B2 (en) |
| EP (1) | EP1265614B1 (en) |
| JP (1) | JP4945043B2 (en) |
| KR (1) | KR100814191B1 (en) |
| CN (1) | CN100396284C (en) |
| AT (1) | ATE296632T1 (en) |
| AU (2) | AU2001240653B9 (en) |
| BE (1) | BE1013487A3 (en) |
| BG (1) | BG66111B1 (en) |
| BR (1) | BRPI0108041B8 (en) |
| CA (1) | CA2400886C (en) |
| CZ (1) | CZ301993B6 (en) |
| DE (1) | DE60111196T2 (en) |
| DZ (1) | DZ3273A1 (en) |
| EE (1) | EE05098B1 (en) |
| ES (1) | ES2241803T3 (en) |
| FR (1) | FR2805462B1 (en) |
| HK (1) | HK1050138B (en) |
| HR (1) | HRP20020692B1 (en) |
| HU (1) | HU229799B1 (en) |
| IL (2) | IL151205A0 (en) |
| IS (1) | IS2446B (en) |
| MA (1) | MA25576A1 (en) |
| MD (1) | MD3119C2 (en) |
| MX (1) | MXPA02008262A (en) |
| NO (1) | NO329495B1 (en) |
| NZ (1) | NZ520691A (en) |
| OA (1) | OA12183A (en) |
| PL (1) | PL201631B1 (en) |
| PT (1) | PT1265614E (en) |
| RS (1) | RS50291B (en) |
| RU (1) | RU2263506C2 (en) |
| SK (1) | SK286313B6 (en) |
| UA (1) | UA73972C2 (en) |
| WO (1) | WO2001062256A1 (en) |
| ZA (1) | ZA200206042B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2805462B1 (en) * | 2000-02-24 | 2003-08-15 | Therabel Res | NEW ORAL GALENIC FORM WITH EXTENDED RELEASE OF MOLSIDOMINE |
| US7803402B2 (en) * | 2002-07-06 | 2010-09-28 | Sanjeev Khandelwal | Pharmaceutical preparations |
| FR2868314B1 (en) * | 2004-04-05 | 2008-10-24 | Therabel Pharmaceuticals Ltd | NOVEL THERAPEUTIC USE OF MOLSIDOMIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS |
| EP2468269A1 (en) | 2010-11-26 | 2012-06-27 | Universitätsklinikum Münster | Nitric oxide donors in therapy of nitric oxide deficiency-induced disturbances of cerebral microcirculation |
| BE1028879B1 (en) | 2020-12-11 | 2022-07-12 | Europharmaceuticals | Molsidomine Sustained-Release Tablet |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3522191A1 (en) * | 1985-06-21 | 1987-01-15 | Cassella Ag | PHOTOSTABILIZATION OF SYDNONIMINES |
| CN1006522B (en) * | 1986-04-30 | 1990-01-24 | 田道制药有限公司 | Process for sustained preparations |
| HU210921B (en) * | 1990-03-28 | 1995-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them |
| HU212730B (en) * | 1990-03-28 | 1996-10-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them |
| DE4140192C2 (en) * | 1991-12-05 | 1996-02-29 | Alfatec Pharma Gmbh | Sol-controlled gelatin-based thermocolloid matrix for peroral sustained release forms |
| ES2139032T3 (en) * | 1993-05-11 | 2000-02-01 | Hoechst Ag | GALLENIC COMPOSITIONS BASED ON MOLSIDOMINE. |
| WO1995001767A1 (en) * | 1993-07-08 | 1995-01-19 | Cygnus Therapeutic Systems | Monolithic matrix transdermal delivery system |
| IT1266565B1 (en) * | 1993-07-22 | 1997-01-09 | Ct Lab Farm Srl | PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE ON THE BASIS OF ONE OR MORE PHARMACEUTICALLY ACCEPTABLE SALTS OF THE RANGE-HYDROXY-BUTYRIC ACID. |
| HU218280B (en) * | 1994-04-26 | 2000-07-28 | Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes | |
| DE4443105C2 (en) * | 1994-12-03 | 1997-03-13 | Hoechst Ag | Process for the production of tablets containing molsidomine |
| JPH09114680A (en) * | 1995-10-19 | 1997-05-02 | Fuji Xerox Co Ltd | Sequence controller |
| IT1282576B1 (en) * | 1996-02-06 | 1998-03-31 | Jagotec Ag | PHARMACEUTICAL TABLET SUITABLE TO GIVE THE ACTIVE SUBSTANCE IN SUBSEQUENT AND PREDETERMINABLE TIMES |
| PE57198A1 (en) * | 1996-03-25 | 1998-10-10 | American Home Prod | PROLONGED RELEASE FORMULA |
| AU9496798A (en) * | 1997-09-19 | 1999-04-05 | Shire Laboratories, Inc. | Solid solution beadlet |
| FR2775188B1 (en) * | 1998-02-23 | 2001-03-09 | Lipha | IMMEDIATE RELEASE ORAL EXTENDED RELEASE GALENIC FORM COMPRISING AN ABSORPTION PROMOTING AGENT AND USE OF THE ABSORPTION PROMOTING AGENT |
| FR2805462B1 (en) * | 2000-02-24 | 2003-08-15 | Therabel Res | NEW ORAL GALENIC FORM WITH EXTENDED RELEASE OF MOLSIDOMINE |
-
2000
- 2000-02-24 FR FR0002307A patent/FR2805462B1/en not_active Expired - Lifetime
-
2001
- 2001-02-22 AU AU2001240653A patent/AU2001240653B9/en not_active Expired
- 2001-02-22 SK SK1220-2002A patent/SK286313B6/en not_active IP Right Cessation
- 2001-02-22 NZ NZ520691A patent/NZ520691A/en not_active IP Right Cessation
- 2001-02-22 IL IL15120501A patent/IL151205A0/en active IP Right Grant
- 2001-02-22 PL PL357550A patent/PL201631B1/en unknown
- 2001-02-22 AT AT01911692T patent/ATE296632T1/en active
- 2001-02-22 JP JP2001561321A patent/JP4945043B2/en not_active Expired - Lifetime
- 2001-02-22 OA OA1200200258A patent/OA12183A/en unknown
- 2001-02-22 UA UA2002086983A patent/UA73972C2/en unknown
- 2001-02-22 EE EEP200200472A patent/EE05098B1/en unknown
- 2001-02-22 AU AU4065301A patent/AU4065301A/en active Pending
- 2001-02-22 BE BE2001/0121A patent/BE1013487A3/en not_active IP Right Cessation
- 2001-02-22 DE DE60111196T patent/DE60111196T2/en not_active Expired - Lifetime
- 2001-02-22 KR KR1020027010441A patent/KR100814191B1/en active IP Right Grant
- 2001-02-22 CN CNB018052592A patent/CN100396284C/en not_active Expired - Lifetime
- 2001-02-22 RS YUP-622/02A patent/RS50291B/en unknown
- 2001-02-22 US US10/182,718 patent/US7767227B2/en not_active Expired - Fee Related
- 2001-02-22 CA CA2400886A patent/CA2400886C/en not_active Expired - Lifetime
- 2001-02-22 HU HU0300607A patent/HU229799B1/en unknown
- 2001-02-22 PT PT01911692T patent/PT1265614E/en unknown
- 2001-02-22 RU RU2002121503/15A patent/RU2263506C2/en active
- 2001-02-22 WO PCT/EP2001/002055 patent/WO2001062256A1/en active IP Right Grant
- 2001-02-22 MX MXPA02008262A patent/MXPA02008262A/en active IP Right Grant
- 2001-02-22 ES ES01911692T patent/ES2241803T3/en not_active Expired - Lifetime
- 2001-02-22 DZ DZ013273A patent/DZ3273A1/en active
- 2001-02-22 MD MDA20020212A patent/MD3119C2/en active IP Right Grant
- 2001-02-22 BR BRPI0108041A patent/BRPI0108041B8/en not_active IP Right Cessation
- 2001-02-22 CZ CZ20022876A patent/CZ301993B6/en not_active IP Right Cessation
- 2001-02-22 EP EP01911692A patent/EP1265614B1/en not_active Expired - Lifetime
-
2002
- 2002-07-29 ZA ZA200206042A patent/ZA200206042B/en unknown
- 2002-08-06 MA MA26765A patent/MA25576A1/en unknown
- 2002-08-12 IL IL151205A patent/IL151205A/en unknown
- 2002-08-14 IS IS6504A patent/IS2446B/en unknown
- 2002-08-22 HR HR20020692A patent/HRP20020692B1/en not_active IP Right Cessation
- 2002-08-22 BG BG107027A patent/BG66111B1/en unknown
- 2002-08-23 NO NO20024043A patent/NO329495B1/en not_active IP Right Cessation
-
2003
- 2003-03-27 HK HK03102218.9A patent/HK1050138B/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002239397A1 (en) | Drug formulation having improved oral tolerability | |
| AU2276801A (en) | Extended release oral dosage composition | |
| AU2277101A (en) | Stable extended release oral dosage composition | |
| AU2001248769A1 (en) | Time-release coated solid compositions for oral administration | |
| AU762322C (en) | Novel galenic formulations of meloxicam for oral administration | |
| AU4024100A (en) | Anti-caries oral care compositions | |
| AU2001287977A1 (en) | Controlled release formulations for oral administration | |
| AU2003226189A1 (en) | Oral administration of epothilones | |
| AU2001284444A1 (en) | Preparations for oral administration | |
| AU2002258221A1 (en) | Medicinal composition | |
| AU2002214324A1 (en) | Medicinal compositions | |
| AU2002360717A1 (en) | Controlled release dosage form having improved drug release properties | |
| AU2001272314A1 (en) | Oral formulations for localized colonic release and the method of preparation thereof | |
| AU2001290239A1 (en) | Medicinal composition | |
| AU2001248772A1 (en) | Sustained release drug compositions | |
| AU2001232948A1 (en) | Controlled release of drugs | |
| AU2001240653A1 (en) | Novel galenical form for oral administration with prolonged release of molsidomine | |
| AU1732401A (en) | Medicinal compositions for oral use | |
| HUP0201667A3 (en) | Oral form of administration | |
| HUP0300607A3 (en) | Novel galenical composition for oral administration with prolonged release of molsidomine | |
| AU2003284786A1 (en) | Microemulsion composition for oral administration of biphenyldimethyldicarboxylate | |
| AU2001252728A1 (en) | Solid dispersion of ipriflavone for oral administration and its manufacturing methods | |
| AU2001241187A1 (en) | Sustained release oral preparations | |
| AU5241200A (en) | Retard formulation of amoxicillin for oral administration | |
| AU3074700A (en) | Medicinal compositions with improved oral absorption |